Breast Cancer Research Foundation

The approval comes after a clinical trial update that involved Breast Cancer Research Foundation investigators. Key Takeaways The FDA has approved adding tucatinib, an oral tyrosine kinase inhibitor, to trastuzumab and pertuzumab for maintenance treatment for patients with HER2-positive metastatic breast cancer. Results from the HER2CLIMB-05 trial, led by BCRF researc...

Thousands joined the Breast Cancer Research Foundation at Grand Central’s Vanderbilt Hall to highlight the importance of research. The event featured Broadway and ballet performances, opportunities to donate, and more.

The Breast Cancer Research Foundation (BCRF) marked the start of

What to know about breast cancer in the months to years after giving birth.

Breast cancer can be diagnosed at any stage of a woman’s life, including in the months and years after giving birth. Postpartum breast cancer is not widely talked about, but it is more common in

At 35, when a mammogram didn’t reveal her cancer, additional imaging and a biopsy helped uncover what was hiding beneath the surface.

Alyssa Butts sat poolside on vacation in Arizona in 2024 when she received a phone call that changed her life. A few days prior, she underwent a planned

The mother of three felt a lump while breast feeding her newborn—it took months to receive a diagnosis.

At just 33, Christina Thammasen noticed a lump on her breast. Having just given birth, doctors assured the mother of three she was fine, and not to worry.

As a military dependent, she went to her doctor at the nearby military treatment hospital and was given in...